Roche win boosts case for adding chemo to cancer immunotherapy Ruby Khatun Khatun23 Nov 2017 9:30 AM ISTLONDON: Cancer doctors struggling to work out the best way to use modern immunotherapy drugs now have further evidence of the benefits of adding them...
Roche stock up 12 billion dollars on cancer, hemophilia trials; rivals hit Ruby Khatun Khatun22 Nov 2017 10:00 AM ISTZURICH: Roche shares were lifted on Monday by two trial wins for its new cancer and hemophilia drugs, potential blockbusters that the Swiss drugmaker...
FDA expands approval for Pfizer cancer drug Studnt Ruby Khatun Khatun20 Nov 2017 10:07 AM ISTThe U.S. Food and Drug Administration (FDA) approved Sutent (sunitinib malate) for the adjuvant treatment of adult patients who are at a high risk of...
Zydus Cadila gets USFDA nod for swelling reducing drug Ruby Khatun Khatun20 Nov 2017 10:02 AM ISTNew Delhi: Zydus Cadila has received final approval from the US health regulator to market Ethacrynate sodium for injection, used to reduce swelling...
This 5 billion dollars startup made its first Cancer vaccine - for just one person Ruby Khatun Khatun18 Nov 2017 10:15 AM ISTBy Caroline ChenFor Moderna Therapeutics, the road to a cancer breakthrough begins on the back of a FedEx truck.Six weeks ago, a 1-millimeter cube of...
FDA approves intravenous version of Tesaro drug for chemotherapy nausea Ruby Khatun Khatun28 Oct 2017 9:44 AM ISTTesaro Inc said on Wednesday that the U.S. Food and Drug Administration (FDA) approved an intravenous version of its drug to treat...
Roche Perjeta regimen gets FDA priority review in breast cancer Ruby Khatun Khatun4 Oct 2017 9:20 AM ISTZURICH: The U.S. Food and Drug Administration (FDA) has granted a priority review for Roche's Perjeta in combination with Herceptin and chemotherapy...
Roche cancer immunotherapy Tecentriq wins EU approval Ruby Khatun Khatun25 Sept 2017 10:17 AM ISTZURICH: Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.The...
Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries Ruby Khatun Khatun25 Sept 2017 9:21 AM ISTBasel: Novartis announced a new collaboration with The Max Foundation to support continued access to treatment at no cost for nearly 34,000 current...
Novartis Rydapt wins EU approval for AML, other diseases Ruby Khatun Khatun22 Sept 2017 9:57 AM ISTZURICH: Swiss drugmaker Novartis on Wednesday won European Union approval for Rydapt to be used against a mutated form of acute myeloid leukemia (AML)...
NPPA slashes price of 39 drugs: check out details Ruby Khatun Khatun21 Sept 2017 10:34 AM ISTNew Delhi: Drug price regulator NPPA on Wednesday said it has fixed the ceiling price for 39 more drug formulations, including those used for the...
After melanoma surgery, Bristols Opdivo offers new care standard Ruby Khatun Khatun12 Sept 2017 9:15 AM ISTMADRID: Bristol-Myers Squibb's immunotherapy drug Opdivo is a better and safer option than its older medicine Yervoy for treating melanoma patients...
